Physician

Hal Marcus Weitzbuch, M.D., M.S., FAAD

According to 2025 Medicare claims, Hal Weitzbuch, M.D., M.S., FAAD (NPI: 1669629317) practices dermatology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is HAL M. WEITZBUCH, M.D. MEDICAL CORPORATION (NPI: 1639420177; TIN: 46-0590520) and primary practice location at 91320-6440.

Weitzbuch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,691 traditional Medicare patients, billed 33,361 HCPCS/CPT codes, and received $1,190,155 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 833 prescription claims across 426 beneficiaries totaling $257,188 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 118 records totaling $67,766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $175,431 to $1,190,155. Similarly, Part D prescription costs have risen steadily, from $19,170 to $257,188. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	378	2,756	$175,431
2016	497	3,733	$230,706
2017	641	4,347	$323,182
2018	735	5,049	$377,728
2019	845	8,968	$452,582
2020	900	10,191	$413,300
2021	1,023	19,136	$504,897
2022	1,147	22,241	$565,481
2023	1,428	24,445	$732,177
2024	1,691	33,361	$1,190,155

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	112	246	$19,170
2016	126	276	$22,574
2017	189	468	$109,055
2018	241	519	$126,877
2019	372	884	$144,646
2020	385	870	$189,792
2021	409	880	$201,729
2022	440	884	$147,381
2023	470	962	$150,156
2024	426	833	$257,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	694	917	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,031	1,684	$76
17000	Destruction of precancer skin growth, 1 growth	900	1,370	$43
88305	Pathology examination of tissue using a microscope, intermediate complexity	753	1,596	$31
17003	Destruction of precancer skin growth, 2-14 growths	699	4,461	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	18	504	$133,676
Dupixent Pen	Dupilumab	14	532	$70,518
Clobetasol Propionate	Clobetasol Propionate	90	2,288	$5,376
Pimecrolimus	Pimecrolimus	15	435	$3,761
Fluorouracil	Fluorouracil	35	911	$2,515

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$67,766	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hal Marcus Weitzbuch, M.D., M.S., FAAD?

Tedicare shows public-source Medicare data for Hal Marcus Weitzbuch, M.D., M.S., FAAD (NPI 1669629317), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hal Marcus Weitzbuch, M.D., M.S., FAAD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hal Marcus Weitzbuch, M.D., M.S., FAAD?

Hal Marcus Weitzbuch, M.D., M.S., FAAD is linked to HAL M. WEITZBUCH, M.D. MEDICAL CORPORATION (billing NPI 1639420177) in the available physician profile data.

Does Hal Marcus Weitzbuch, M.D., M.S., FAAD have Open Payments data?

Hal Marcus Weitzbuch, M.D., M.S., FAAD has 118 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.